Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis

被引：7
|
作者：
Pinto, R. S. [1 ,2 ]
Machado, U. F. [3 ]
Passarelli, M. [1 ,4 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Lab Lipides LIM 10, Sao Paulo, Brazil
[2] Ctr Univ CESMAC, Maceio, Alagoas, Brazil
[3] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, Sao Paulo, Brazil
[4] Univ Nove Julho UNINOVE, Programa Posgrad Med, Sao Paulo, Brazil
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 08期
基金：
巴西圣保罗研究基金会;
关键词：
advanced glycation end products; cardiovascular disease; diabetes mellitus; Maillard reaction; DIABETES-MELLITUS; ALBUMIN; STRESS; MACROPHAGES; PATHWAYS;
D O I：
10.2217/bmm-2020-0060
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：611 / 614
页数：4
相关论文
共 50 条
  • [41] Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients
    Buraczynska, Monika
    Zaluska, Wojciech
    Buraczynska, Kinga
    Markowska-Gosik, Dorota
    Ksiazek, Andrzej
    HUMAN IMMUNOLOGY, 2015, 76 (11) : 843 - 848
  • [42] Advanced glycation end products and the progressive course of renal disease
    Heidland, A
    Sebekova, K
    Schinzel, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S100 - S106
  • [43] Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
    Jiao, Li
    Taylor, Philip R.
    Weinstein, Stephanie J.
    Graubard, Barry I.
    Virtamo, Jarmo
    Albanes, Demetrius
    Stolzenberg-Solomon, Rachael Z.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1430 - 1438
  • [44] Advanced glycation end products (AGEs) and their involvement in liver disease
    Hyogo, Hideyuki
    Yamagishi, Sho-ichi
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 969 - 972
  • [45] Advanced glycation end products in the pathogenesis of chronic kidney disease
    Rabbani, Naila
    Thornalley, Paul J.
    KIDNEY INTERNATIONAL, 2018, 93 (04) : 803 - 813
  • [46] The role of advanced glycation end products in retinal ageing and disease
    Glenn, Josephine V.
    Stitt, Alan W.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10): : 1109 - 1116
  • [47] Dietary Advanced Glycation End Products and Their Role in Health and Disease
    Uribarri, Jaime
    Dolores del Castillo, Mara
    Pia de la Maza, Mara
    Filip, Rosana
    Gugliucci, Alejandro
    Luevano-Contreras, Claudia
    Macias-Cervantes, Maciste H.
    Markowicz Bastos, Deborah H.
    Medrano, Alejandra
    Menini, Teresita
    Portero-Otin, Manuel
    Rojas, Armando
    Sampaio, Geni Rodrigues
    Wrobel, Kazimierz
    Wrobel, Katarzyna
    Eugenia Garay-Sevilla, Ma
    ADVANCES IN NUTRITION, 2015, 6 (04) : 461 - 473
  • [48] Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
    Carrion-Barbera, Irene
    Triginer, Laura
    Tio, Laura
    Perez-Garcia, Carolina
    Ribes, Anna
    Abad, Victoria
    Pros, Ana
    Bermudez-Lopez, Marcelino
    Castro-Boque, Eva
    Lecube, Albert
    Valdivielso, Jose Manuel
    Monfort, Jordi
    Salman-Monte, Tarek Carlos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [49] Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
    Chiu, Chung-Jung
    Rabbani, Naila
    Rowan, Sheldon
    Chang, Min-Lee
    Sawyer, Sherilyn
    Hu, Frank B.
    Willett, Walter
    Thornalley, Paul J.
    Anwar, Attia
    Bar, Liliana
    Kang, Jae H.
    Taylor, Allen
    BIOFACTORS, 2018, 44 (03) : 281 - 288
  • [50] Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease
    Reichert, Stefan
    Triebert, Ulrike
    Santos, Alexander Navarrete
    Hofmann, Britt
    Schaller, Hans-Guenter
    Schlitt, Axel
    Schulz, Susanne
    ATHEROSCLEROSIS, 2017, 266 : 234 - 239
12345